GNH USA

Europe — EMA

Ondansetron Aristo (Ondansetron Hydrochloride Dihydrate)

GNH USA supplies Ondansetron Aristo (Ondansetron), a 5-HT3 receptor antagonist for chemotherapy, radiotherapy and postoperative nausea.

Ondansetron Hydrochloride Dihydrate

Request sourcing

1
Pack/s

What is Ondansetron Hydrochloride Dihydrate?

Ondansetron Hydrochloride Dihydrate, the active ingredient in Ondansetron Aristo, is a 5-HT3 receptor antagonist presented as an injection for intravenous use. It is used to prevent nausea and vomiting associated with chemotherapy, radiotherapy and postoperative recovery in adult and pediatric patients.

GNH USA supplies Ondansetron Aristo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Ondansetron Hydrochloride Dihydrate used for?

Ondansetron Aristo is a selective 5‑HT3 receptor antagonist used in the management of nausea and vomiting pathways. - Chemotherapy‑induced nausea and vomiting: helps control the acute and delayed phases, improving patient comfort during cancer treatment. - Radiotherapy‑induced nausea and vomiting: reduces the frequency and severity of nausea associated with radiation sessions. - Post‑operative nausea and vomiting: decreases the incidence of nausea and vomiting after surgical procedures, supporting faster recovery.

What are the side effects of Ondansetron Hydrochloride Dihydrate?

Side effects reported with ondansetron injection are generally mild to moderate and vary with individual sensitivity.

Common Side Effects: - Headache: mild to moderate intensity. - Constipation: reduced bowel motility. - Diarrhoea: occasional loose stools. - Fatigue: feeling of tiredness. - Dizziness: transient light‑headedness. - Injection site reactions: erythema or mild pain.

Serious or Rare Side Effects: - Cardiac arrhythmia: QT‑interval prolongation, especially with rapid IV administration. - Severe hypersensitivity: anaphylaxis, angio‑edema, or skin rash. - Serotonin syndrome: rare when combined with other serotonergic agents. - Hepatic dysfunction: elevated liver enzymes. - Neuro‑muscular weakness: rare cases of muscle rigidity. - Pulmonary edema: very rare, usually in high‑risk patients.

What precautions apply to Ondansetron Hydrochloride Dihydrate?

When using Ondansetron Aristo, clinicians should consider several safety measures to minimise risk. - Cardiac monitoring: patients with known QT prolongation or electrolyte disturbances should be monitored. - Concomitant serotonergic drugs: assess risk of serotonin syndrome. - Renal or hepatic impairment: dose adjustment may be required. - Pregnancy and lactation: use only if clearly needed; benefits must outweigh the potential risk. - Pediatric use: weight‑based dosing is essential; follow prescriber guidance. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Ondansetron Hydrochloride Dihydrate interact with?

Ondansetron may interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Apomorphine: may cause profound hypotension and loss of consciousness. - Certain anti‑arrhythmic agents (e.g., quinidine, amiodarone): increase risk of QT prolongation. - Serotonergic antidepressants (SSRIs, SNRIs, MAOIs): heightened risk of serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (ketoconazole, erythromycin): may raise ondansetron plasma levels. - CYP2D6 substrates (tramadol, codeine): potential for altered metabolism. - Diuretics causing electrolyte loss: may exacerbate QT‑interval effects.

Frequently asked questions

What is Ondansetron Aristo used for?+
Ondansetron Aristo is an injectable form of ondansetron hydrochloride dihydrate used to prevent and treat nausea and vomiting that can occur after chemotherapy, radiotherapy or surgery. It is administered intravenously under medical supervision to provide rapid anti‑emetic relief in patients at risk of emetogenic triggers.
How does ondansetron work to stop nausea?+
Ondansetron selectively blocks 5‑HT3 receptors on peripheral vagal nerves and in the brain’s chemoreceptor trigger zone. By preventing serotonin from binding to these receptors, it interrupts the neural pathway that signals the brain to initiate nausea and vomiting, thereby offering effective anti‑emetic protection.
What is the usual dose of Ondansetron Aristo?+
The dosage of Ondansetron Aristo is determined by the prescribing clinician based on the patient’s age, weight, type of emetogenic stimulus and clinical condition. Healthcare professionals set the appropriate dose and infusion rate according to established treatment guidelines.
Is Ondansetron safe during pregnancy or breastfeeding?+
Safety data for ondansetron in pregnancy are limited, and the product is classified as pregnancy category unknown. It should only be used when the potential benefit justifies any potential risk to the fetus. Breastfeeding mothers should consult their physician, as small amounts may be excreted in milk.
How do I order Ondansetron Aristo from GNH USA?+
To order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.
How does Ondansetron compare with other anti‑emetics?+
Ondansetron belongs to the 5‑HT3 receptor antagonist class, offering rapid onset and specific serotonin blockade. Compared with dopamine antagonists (e.g., metoclopramide) it has fewer extrapyramidal side effects and provides superior control of chemotherapy‑induced nausea, though both classes may be used complementarily in some protocols.
What are the storage requirements for Ondansetron Aristo?+
Ondansetron Aristo should be stored at 2‑8 °C, protected from light, and kept in its original packaging. It must not be frozen or shaken, and any solution that has been diluted for infusion should be used within the time frame recommended by the manufacturer.
How is Ondansetron Aristo administered?+
The product is given by intravenous injection or infusion, typically over a few minutes for a single dose or as a continuous infusion for prolonged anti‑emetic coverage. Administration is performed by qualified healthcare personnel in a clinical setting, following aseptic technique.
What are the most serious risks associated with Ondansetron?+
Serious risks include cardiac arrhythmias such as QT‑interval prolongation, severe hypersensitivity reactions (anaphylaxis), and rare cases of serotonin syndrome when combined with other serotonergic drugs. Patients should be monitored for ECG changes and any signs of allergic response during treatment.
Who should not use Ondansetron Aristo?+
Ondansetron is contraindicated in patients with known hypersensitivity to ondansetron or any component of the formulation. Caution is advised for individuals with congenital long QT syndrome, uncontrolled electrolyte imbalances, or those receiving interacting medications that markedly increase QT risk.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Ondansetron Hydrochloride Dihydrate
Route
Intravenous Use
Manufacturer
Aristo Pharma Gmbh (Art 57)
Origin
EU

Related products

Cellondan

Cellondan

Ondansetron Hydrochloride Dihydrate

Stadapharm Gmbh
EU
Cellondan

Cellondan

Ondansetron Hydrochloride Dihydrate

Stadapharm Gmbh
EU
Emeset

Emeset

Ondansetron Hydrochloride Dihydrate

Amring Farma Srl
EU
Emetron

Emetron

Ondansetron Hydrochloride Dihydrate

Gedeon Richter Plc.
EU